[1]毛维维,伊桂叶.不同肥胖类型患者血清代谢指标与内脏脂肪指数的相关性分析[J].现代检验医学杂志,2019,34(05):1-3.[doi:10.3969/j.issn.1671-7414.2019.05.001]
 MAO Wei-wei,YI Gui-ye.Correlation between Serum Metabolic Indexes of Different Obesity Types and Visceral Adiposity Index[J].Journal of Modern Laboratory Medicine,2019,34(05):1-3.[doi:10.3969/j.issn.1671-7414.2019.05.001]
点击复制

不同肥胖类型患者血清代谢指标与内脏脂肪指数的相关性分析()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年05期
页码:
1-3
栏目:
论著
出版日期:
2019-10-29

文章信息/Info

Title:
Correlation between Serum Metabolic Indexes of Different Obesity Types and Visceral Adiposity Index
文章编号:
1671-7414(2019)05-001-04
作者:
毛维维伊桂叶
(上海市第一康复医院内分泌与肾脏功能代谢科,上海 200090)
Author(s):
MAO Wei-weiYI Gui-ye
(Department of Endocrinology and Renal Function Metabolism,Shanghai First Rehabilitation Hospital,Shanghai 200090,China)
关键词:
肥胖类型 中心性肥胖 代谢指标 内脏脂肪指数
分类号:
R446.112
DOI:
10.3969/j.issn.1671-7414.2019.05.001
文献标志码:
A
摘要:
目的 探讨不同肥胖类型代谢指标与内脏脂肪指数(VAI)的相关性。方法 选择2017年1~12月上海市第一康复医院收治的110例肥胖患者,按照肥胖类型分为中心性肥胖(n=74)和非中心性肥胖(n=36),同时选择50例健康体检者作为对照组,采集体质量指数(BMI)、腰围(WC)、血脂、血糖和血尿酸(UA)等临床资料,计算VAI,分析不同肥胖类型患者代谢指标差异及其与VAI的相关性。结果 与对照组比较,非中心性肥胖组患者BMI(25.15±3.66 vs 21.46±2.54 kg/m2),WC(87.29±5.88 vs 79.26±4.87cm),TG(0.83±0.16 vs 0.52±0.12 mmol/L),TC(4.57±0.34 vs 4.22±0.32 mmol/L),LDL-C(2.73±0.36 vs 2.35±0.47 mmol/L)及VAI(1.59±0.38 vs 1.20±0.47)水平明显升高,HDL-C(1.24±0.35 vs 1.81±0.44 mmol/L)明显降低(t=3.6911.50,P<0.05); 与非中心性肥胖组比较,中心性肥胖组WC(89.80±6.13 vs 87.29±5.88cm),TG(1.14±0.35 vs 0.83±0.16mmol/L),TC(4.81±0.45 vs 4.57±0.34 mmol/L),LDL-C(3.02±0.35 vs 2.73±0.36 mmol/L),FPG(7.31±1.32 vs 6.09±1.45 mmol/L),2h PG(12.13±1.95 vs 8.34±1.49 mmol/L),UA(328.25±24.67 vs 287.19±29.23 μmol/L)及VAI(3.31±0.82 vs 1.59±0.38)水平明显升高,HDL-C(0.83±0.23 vs 1.24±0.35 mmol/L)明显降低(t=2.167.45,P值均<0.05)。中心性肥胖患者VAI与BMI,WC,血糖、血脂及UA呈显著相关(r=0.380.45,P<0.05); 非中心性肥胖患者VAI与BMI,WC,TC呈显著正相关,与HDL-C呈显著负相关(r=0.300.40,P<0.05)。多元线性回归显示,WC,TG,肥胖类型(中心性)和UA是VAI的危险因素,HDL-C则是保护因素(t=2.0263.413,P<0.05)。结论 中心性肥胖较非中心性肥胖患者更容易出现代谢功能异常,VAI与代谢指标密切相关,可反映不同类型肥胖患者代谢状态。
Abstract:
Objective To investigate the correlation between metabolic indexes of different obesity types and visceral adiposity index(VAI).Methods 110 cases of obese patients from 2017.1 to 2017.12 and 50 cases of healthy control in Shanghai First Rehabilitation Hospitalwere selected,obese patients was divided into central obesity(n=74)and non-central obesity(n=36)according to the obesity type.The body mass index(BMI),waist circumference(WC),blood lipid,blood glucose,blood uric acid(UA)and other clinical data were collected,VAI was calculated,and the difference in metabolic indexes of patients with different obesity types and their correlation with VAI were analyzed.Results Compared with control group,the levels of BMI(25.15±3.66 vs 21.46±2.54 kg/m2),WC(87.29±5.88 vs 79.26±4.87 cm),TG(0.83±0.16 vs 0.52±0.12 mmol/L),TC(4.57±0.34 vs 4.22±0.32 mmol/L),LDL-C(2.73±0.36 vs 2.35±0.47 mmol/L)and VAL(1.59±0.38 vs 1.20±0.47)in non-central obesity group were significantly increased,while HDL-C(1.24±0.35 vs 1.81±0.44mmol/L)level were significantly decreased(t=3.69~11.50,all P<0.05).Compared withnon-central obesity group,the levels of WC(89.80±6.13 vs 87.29±5.88cm),TG(1.14±0.35 vs 0.83±0.16 mmol/L),TC(4.81±0.45 vs 4.57±0.34 mmol/L),LDL-C(3.02±0.35 vs 2.73±0.36 mmol/L),FPG(7.31±1.32 vs 6.09±1.45 mmol/L),2h PG(12.13±1.95 vs 8.34±1.49 mmol/L),UA(328.25±24.67 vs 287.19±29.23 μmol/L)and VAL(3.31±0.82 vs 1.59±0.38)in central obesity group were significantly increased,while HDL-C(0.83±0.23 vs 1.24±0.35 mmol/L)level were significantly decreased(t=2.16~7.45,all P<0.05).VAI was significantly correlated with BMI,WC,blood glucose,blood lipid and UA in patients with central obesity(r=0.38~0.45,all P<0.05).In patients with non-central obesity,VAI was positivelycorrelated with BMI,WC and TC,and negatively correlated with HDL-C(r=0.30~0.40,all P<0.05).Multiple linear regression showed that WC,TG,obesity type(centrality)and UA were risk factors for VAI,while HDL-C was a protective factor(t=2.026~3.413,all P<0.05).Conclusion Compared with patients with non-central obesity,patients with centralobesity were more likely to have abnormal metabolic functions.VAI was closelyrelated to metabolic indicators and can reflect the metabolic status of patientswith different types of obesity.

参考文献/References:

[1] NG M,FLEMING T,ROBINSON M,et al.Global,regional,and national prevalence of overweight and obesity in children and adults during 1980-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2014,384(9945):766-781. [2] DAVIS C R,DEARING E U,SHER N,et al.Detailed assessments of childhoodadversity enhance prediction of central obesity independent of gender,race,adult psychosocial risk and health behaviors[J].Metabolism,2014,63(2):199-206. [3] ELSAID H W,MOHAMED O M,ELSAID T W,et al.Central obesity and risks ofcardiovascular events and mortality in prevalent hemodialysis patients[J].International Urology & Nephrology,2017,49(7):1251-1260. [4] AMATO M C,PIZZOLANTI G,TORREGROSSA V,et al.Visceral adiposity index(VAI)is predictive of an altered adipokine profile in patients with type 2 diabetes[J].PLoS One,2014,9(7):e91969. [5] 中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006. Department of Disease Control,Ministry of Health,People's Republic of China.Chinese guidelines for the prevention and control of overweight andobesity in adults[M].Beijing:People's Medical Publishing House,2006. [6] AMATO M C,GIORDANO C,GALIA M,et al.Visceral adiposity index:a reliable indicator of visceral fat function associated with cardiometabolic risk[J].Diabetes Care,2010,33(4):920-922. [7] 中华人民共和国国家卫生和计划生育委员会.WS/T 428-2013成人体重判定[S].北京:中国标准出版社,2013. National Health and Family Plannig Commission of People's Republicof China.WS/T428-2013 Crieria of weight for adults[S].Beijing:China Standard Publishing House,2013. [8] 顾进,侯思南,许海英.中性粒细胞淋巴细胞比率在衡量肥胖病人炎症状态的初步探讨[J].现代检验医学杂志,2016,31(6):147-149. GU Jin,HOU Sinan,XU Haiying.Preliminary study on neutrophil-lymphocyte ratio as an indicator of inflammatory state in obese patients[J].Journal of Modern Laboratory Medicine,2016,31(6):147-149. [9] 赵俊,隋忠国,辛晓玮,等.腹型肥胖对成人2型糖尿病患者胰岛素抵抗、分泌功能的影响[J].中国生化药物杂志,2016,36(7):19-21. ZHAO Jun, SUI Zhongguo, XIN Xiaowei,et al.Effects of abdominal obesity on insulin resistance and secretion in adults patients with type 2 diabetes[J].Chinese Journal of Biochemical and Phamace,2016,36(7):19-21. [10] PAYAB M,AMOLI M M,QORBANI M,et al.Adiponection gene variantsand abdominal obesity in an Iranian population[J].Eat Weight Disord,2017,22(1):85-90. [11] PARK H J,KIM J,PARK S E,et al.Increased risk of subclinical atherosclerosis associated with high visceral adiposity index in apparently healthy Korean adults:the Kangbuk Samsung Health Study[J].Ann Med,2016,48(6):410-416. [12] MOHAMMADREZA B, FARZAD H, DAVOUD K,et al.Prognostic significance ofthe complex“Visceral Adiposity Index”VS.simple anthropometric measures:Tehran lipid and glucose study[J].Cardiovasc Diabetol,2012,11:20. [13] DIVOUX A,MOUTEL S,POITOU C,et al.Mast cells in human adipose tissue:Link with morbid obesity, inflammatory status,and diabetes[J].J Clin Endocrinol Metab,2017,97(9):E1677-E1685. [14] ALDAGHRI N M,ALATTAS O S,ALOKAIL M S,et al.Visceral adiposity indexis highly associated with adiponectin values and glycaemic disturbances[J].Eur J Clin Invest,2013,43(4):183-189. [15] 李庆,刘婵,夏佳佳,等.内脏脂肪指数对成人生长激素缺乏症患者代谢综合征的评估作用研究[J].中国全科医学,2017,20(4):437-442. LI Qing,LIU Chan,XIA Jiajia,et al.Value of visceral adiposity index inpredictng metabolic syndrome in adults growth hormone deficiency[J].ChineseGeneral Practice,2017,20(4):437-442.

备注/Memo

备注/Memo:
作者简介:毛维维(1981-),女,硕士,主治医师,研究方向:内分泌代谢,E-mail:weiwei1981_2@sina.com。 通讯作者:伊桂叶,副主任医师,E-mail:syrscl@126.com。
更新日期/Last Update: 2019-10-20